Study of Enasidenib and Venetoclax in IDH2-Mutated Blood Cancers
Clinical trial NCT04092179 · TERMINATED
Trial details
- NCT number
- NCT04092179
- Sponsor
- University Health Network, Toronto
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-05
- Primary completion
- 2023-10-26
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.